{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:29:19Z","timestamp":1761766159316},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"No Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12886-017-0433-3","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T18:54:19Z","timestamp":1491332059000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of Intravitreal injection of 2-Methoxyestradiol in regression of neovascularization of a retinopathy of prematurity rat model"],"prefix":"10.1186","volume":"17","author":[{"given":"Azza Mohamed Ahmed","family":"Said","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania Gamal Eldin","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania A.","family":"Salah Eldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar Saad","family":"Azab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser Abdelmageuid","family":"Elzankalony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"433_CR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10633-009-9193-6","volume":"120","author":"EL Fletcher","year":"2010","unstructured":"Fletcher EL, Downie LE, Hatzopoulos K, et al. The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy. Doc Ophthalmol. 2010;120:67\u201386.","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"433_CR2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032167","volume":"7","author":"S Nakamura","year":"2012","unstructured":"Nakamura S, Imai S, Ogishima H, Tsuruma K, Shimazawa M, Hara H. Morphological and functional changes in the retina after chronic oxygen-induced retinopathy. PLoS One. 2012;7(2):e32167.","journal-title":"PLoS One"},{"issue":"3","key":"433_CR3","first-page":"227","volume":"79","author":"C Gilbert","year":"2000","unstructured":"Gilbert C, Foster A. Childhood blindness in the context of Vision 2020-the right to sight. Bull World Health Organ. 2000;79(3):227\u201332.","journal-title":"Bull World Health Organ"},{"key":"433_CR4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/eye.2009.306","volume":"24","author":"A Scott","year":"2010","unstructured":"Scott A, Fruttiger M. Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye. 2010;24:416\u201321.","journal-title":"Eye"},{"key":"433_CR5","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A, et al. Oxygen induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"433_CR6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor KM, Krah NM, Dennison RJ, et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc. 2009;4(11):1565\u201373.","journal-title":"Nat Protoc"},{"key":"433_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0076-6879(08)02806-1","volume":"444","author":"E Aguilar","year":"2008","unstructured":"Aguilar E, Dorrell MI, Friedlander D, et al. Chapter 6 ocular models of angiogenesis. Methods Enzymol. 2008;444:115\u201358.","journal-title":"Methods Enzymol"},{"key":"433_CR8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.yexcr.2005.10.030","volume":"312","author":"A Uemura","year":"2006","unstructured":"Uemura A, Kusuhara S, Katsuta H, Nishikawa S. Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp Cell Res. 2006;312:676\u201383.","journal-title":"Exp Cell Res"},{"key":"433_CR9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","volume":"27","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27:622\u201347.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"433_CR10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tem.2009.04.007","volume":"20","author":"RK Dubey","year":"2009","unstructured":"Dubey RK, Jackson EK. Potential vascular actions of 2-methoxyestradiol. Trends Endocrinol Metab. 2009;20(8):374\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"433_CR11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1755-3768.2010.01963.x","volume":"90","author":"I Akkoyun","year":"2012","unstructured":"Akkoyun I, Karabay G, Haberal N, et al. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model. Acta Ophthalmol. 2012;90:564\u201370.","journal-title":"Acta Ophthalmol"},{"key":"433_CR12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1600-0420.2007.00945.x","volume":"85","author":"I Akkoyun","year":"2007","unstructured":"Akkoyun I, Yilmaz G, Oto S, Kahraman B, Haberal N, Akova YA. Impact of triamicinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model. Acta Ophthalmol Scand. 2007;85:791\u20134.","journal-title":"Acta Ophthalmol Scand"},{"key":"433_CR13","first-page":"237","volume-title":"Carleton's Histological techniques","author":"R Drury","year":"1980","unstructured":"Drury R, Wallington E. Carleton's Histological techniques. 5th ed. New York: Oxford University Press; 1980. p. 237.","edition":"5"},{"issue":"9","key":"433_CR14","first-page":"5725","volume":"7","author":"N Youssef","year":"2014","unstructured":"Youssef N, Said A. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies. Int J Clin Exp Pathol. 2014;7(9):5725\u201337.","journal-title":"Int J Clin Exp Pathol"},{"key":"433_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/glia.10061","volume":"38","author":"H Chen","year":"2002","unstructured":"Chen H, Weber A. Expression of glial fibrillary acidic protein and glutamine synthetase by M\u00fcller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor. Glia. 2002;38:115\u201325.","journal-title":"Glia"},{"issue":"2","key":"433_CR16","first-page":"496","volume":"43","author":"X Gu","year":"2002","unstructured":"Gu X, Samuel S, El-Shabrawey M, et al. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2002;43(2):496\u2013502.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"433_CR17","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jps.20837","volume":"96","author":"NJ Lakhani","year":"2007","unstructured":"Lakhani NJ, Sparreboom A, Xu X, et al. Pharmacokinetics, pharmacodynamics and drug metabolism - characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2 methoxyestradiol. J Pharm Sci. 2007;96:1821\u201331.","journal-title":"J Pharm Sci"},{"key":"433_CR18","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1167\/iovs.03-0490","volume":"44","author":"CK Yeung","year":"2003","unstructured":"Yeung CK, Chan KP, Chiang SW, Pang CP, Lam DS. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci. 2003;44:5293\u2013300.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"433_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10384-003-0053-8","volume":"48","author":"CK Yeung","year":"2004","unstructured":"Yeung CK, Chan KP, Chan CK, Pang CP, Lam DS. Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone. Jpn J Ophthalmol. 2004;48:236\u201342.","journal-title":"Jpn J Ophthalmol"},{"key":"433_CR20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/bjo.2004.052563","volume":"89","author":"UHM Spandau","year":"2005","unstructured":"Spandau UHM, Sauder G, Schbert U, Hammes HP, Jonas JB. Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo. Br J Ophthalmol. 2005;89:745\u20137.","journal-title":"Br J Ophthalmol"},{"key":"433_CR21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1167\/iovs.05-0772","volume":"47","author":"R Narayanan","year":"2006","unstructured":"Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci. 2006;47:722\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"433_CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/368237a0","volume":"368","author":"T Fotsis","year":"1994","unstructured":"Fotsis T, Zhang Y, Pepper MS, et al. The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor-growth. Nature. 1994;368:237\u20139.","journal-title":"Nature"},{"key":"433_CR23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.vph.2006.05.007","volume":"45","author":"SP Tofovic","year":"2006","unstructured":"Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline induced pulmonary hypertension. Vasc Pharmacol. 2006;45:358\u201367.","journal-title":"Vasc Pharmacol"},{"key":"433_CR24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.1780400120","volume":"40","author":"E Josefsson","year":"1997","unstructured":"Josefsson E, Tarkowski A. Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis and Rheum. 1997;40:154\u201363.","journal-title":"Arthritis and Rheum"},{"key":"433_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","volume":"3","author":"NJ Mabjeesh","year":"2003","unstructured":"Mabjeesh NJ, Escuin D, Lavallee TM, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 2003;3:363\u201375.","journal-title":"Cancer Cell"},{"key":"433_CR26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2353\/ajpath.2008.061244","volume":"172","author":"CM Becker","year":"2008","unstructured":"Becker CM, Rohwer N, Funakoshi T, et al. 2-methoxyestradiol inhibits hypoxia-inducible factor-1 alpha and suppresses growth of lesions in a mouse model of endometriosis. Amr J Path. 2008;172:534\u201344.","journal-title":"Amr J Path"},{"key":"433_CR27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u201332.","journal-title":"Nat Rev Cancer"},{"key":"433_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/exer.2001.1132","volume":"74","author":"MR Robinson","year":"2002","unstructured":"Robinson MR, Baffi J, Yuan P, Sung C, Byrnes G. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. Exp Eye Res. 2002;74:309\u201317.","journal-title":"Exp Eye Res"},{"issue":"5","key":"433_CR29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.exer.2006.05.016","volume":"83","author":"T Funakoshi","year":"2006","unstructured":"Funakoshi T, Birsner AE, D'Amato RJ. Antiangiogenic effect of oral 2 methoxyestradiol on choroidal neovascularization in mice. Exp Eye Res. 2006;83(5):1102\u20137.","journal-title":"Exp Eye Res"},{"key":"433_CR30","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2353\/ajpath.2006.050533","volume":"168","author":"AA Kramerov","year":"2006","unstructured":"Kramerov AA, Saghizadeh M, Pan H, et al. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am J Path. 2006;168:1722\u201336.","journal-title":"Am J Path"},{"key":"433_CR31","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","volume":"168","author":"N Jo","year":"2006","unstructured":"Jo N, Mailhos C, Ju M, et al. Inhibition of platelet- derived growth factor B signaling enhances the efficacy of anti - vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Path. 2006;168:2036\u201353.","journal-title":"Am J Path"},{"issue":"7","key":"433_CR32","first-page":"2148","volume":"33","author":"T Chan-Ling","year":"1992","unstructured":"Chan-Ling T, Stone J. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. Invest Ophthalmol Vis Sci. 1992;33(7):2148\u201359.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"433_CR33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/cne.21449","volume":"504","author":"LE Downie","year":"2007","unstructured":"Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity. J Comp Neurol. 2007;504(4):404\u201317.","journal-title":"J Comp Neurol"},{"issue":"7","key":"433_CR34","doi-asserted-by":"crossref","first-page":"e22460","DOI":"10.1371\/journal.pone.0022460","volume":"6","author":"SP Narayanan","year":"2011","unstructured":"Narayanan SP, Suwanpradid J, Saul A, et al. Arginase 2 deletion reduces neuro \u2013 glial injury and improves retinal function in a model of retinopathy of prematurity. PLoS One. 2011;6(7):e22460.","journal-title":"PLoS One"},{"key":"433_CR35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1755-3768.2009.01565.x","volume":"88","author":"GL Kanthan","year":"2010","unstructured":"Kanthan GL, Wang JJ, Burlutsky G, Rochtchina E, Cumming RG, Mitchell P. Exogenous oestrogen exposure, female reproductive factors and the long-term incidence of cataract: the Blue Mountains eye study. Acta Ophthalmol. 2010;88:773\u20138.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"433_CR36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.185.2.273","volume":"185","author":"AM Hales","year":"1997","unstructured":"Hales AM, Chamberlain CG, Murphy CR, McAvoy JW. Estrogen protects lenses against cataracts induced by transforming group factor-B (TGF beta). J Exp Med. 1997;185(2):273\u201380.","journal-title":"J Exp Med"},{"key":"433_CR37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exer.2003.09.015","volume":"78","author":"ZG Chen","year":"2004","unstructured":"Chen ZG, John M, Subramanian S, Chen H, Carper D. 17-beta-estradiol confers a protective effect against transforming growth factor-beta2-induced cataracts in female but not male lenses. Exp Eye Res. 2004;78:67\u201374.","journal-title":"Exp Eye Res"},{"key":"433_CR38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/archinte.161.11.1448","volume":"161","author":"K Worzala","year":"2001","unstructured":"Worzala K, Hiller R, Sperduto RD, et al. Postmenopausal estrogen use, type of menopause, and lens opacities \u2013 the Framingham studies. Arch Intern Med. 2001;161:1488\u201354.","journal-title":"Arch Intern Med"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-017-0433-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:10:16Z","timestamp":1498385416000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-017-0433-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1186\/s12886-017-0433-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]},"article-number":"38"}}